Feifei An
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 36
- Graphene and Nanomaterials Applications 7
- Photoacoustic and Ultrasonic Imaging 5
- Biomaterials 25
- Nanoparticle-Based Drug Delivery 24
- Co-authors
- Xiaohong Zhang (19 shared papers)Jinfeng Zhang (8 shared papers)Chun‐Sing Lee (8 shared papers)Ömer Aras (13 shared papers)Jingqi Xin (12 shared papers)Xing‐Jie Liang (4 shared papers)Richard Ting (9 shared papers)Mengjiao Zhou (7 shared papers)
- Journals
- Chinese Chemical Letters (4 papers)PLoS ONE (3 papers)International Journal of Molecular Sciences (3 papers)Journal of Materials Chemistry B (3 papers)Small (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Feifei An
73 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 113
- Biomaterials 791
- Biomedical Engineering 1.3k
- Materials Chemistry 792
- Pharmaceutical Science 92
- Molecular Medicine 69
Countries citing papers authored by Feifei An
This map shows the geographic impact of Feifei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei An more than expected).
Fields of papers citing papers by Feifei An
This network shows the impact of papers produced by Feifei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei An. The network helps show where Feifei An may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 359 | |
| 2 | 2015 | 150 | |
| 3 | 2014 | 150 | |
| 4 | 2021 | 96 | |
| 5 | 2014 | 84 | |
| 6 | 2019 | 83 | |
| 7 | 2020 | 82 | |
| 8 | 2023 | 82 | |
| 9 | 2018 | 73 | |
| 10 | 2022 | 73 | |
| 11 | 2012 | 71 | |
| 12 | 2012 | 61 | |
| 13 | 2020 | 54 | |
| 14 | 2014 | 51 | |
| 15 | 2020 | 51 | |
| 16 | 2014 | 49 | |
| 17 | 2020 | 48 | |
| 18 | 2016 | 45 | |
| 19 | 2020 | 35 | |
| 20 | 2018 | 34 |
About Feifei An
Feifei An is a scholar working on Biomedical Engineering, Biomaterials, Materials Chemistry, Plant Science and Molecular Biology, having authored 74 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (36 papers), Nanoparticle-Based Drug Delivery (24 papers), Luminescence and Fluorescent Materials (18 papers), Cassava research and cyanide (15 papers), Photodynamic Therapy Research Studies (7 papers), Graphene and Nanomaterials Applications (7 papers), Plant Micronutrient Interactions and Effects (5 papers) and Photoacoustic and Ultrasonic Imaging (5 papers). The work is most often cited by research in Biomaterials (791 citations), Biomedical Engineering (1.3k citations), Materials Chemistry (792 citations), Pharmaceutical Science (92 citations) and Molecular Medicine (69 citations). Feifei An has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiaohong Zhang, Jinfeng Zhang, Chun‐Sing Lee, Ömer Aras, Jingqi Xin, Xing‐Jie Liang, Richard Ting, Mengjiao Zhou, Yinlong Yang and Xiujuan Zhang. Their work appears in journals such as Chinese Chemical Letters, PLoS ONE, International Journal of Molecular Sciences, Journal of Materials Chemistry B and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.